Low-Intensity Vibration therapy
A clinically approved, non-drug Class IIa medical device for osteoporosis, bone density, balance and healthy ageing — just 10 minutes a day.
10 min
Daily use
0.4g
Low-intensity signal
30 Hz
Calibrated frequency
<0.1mm
Amplitude
ARTG
317506 listed
Erchonia systems supplied in Australia are listed on the ARTG by the sponsor.
Device claims reference published clinical studies, not marketing copy.
Supplied to physiotherapy, podiatry and chiropractic practices nationally.
Payment is completed on the encrypted RehaCare store.
What the data shows
+2.17%
Bone mineral density improvement (Leung, 2014)
2.1%
Average BMD increase in one-year post-menopausal study
46%
Reduction in falls rate (community-dwelling elderly)
60+
Peer-reviewed studies and trials
Overview
Marodyne LiV uses Low-Intensity Vibration (LiV) to gently stimulate the body's own natural response — increasing bone mineral density, improving blood flow and building muscle strength. It is safe enough for fragile bones, precise enough for a Class IIa medical device, and simple enough for daily home use.
Marodyne LiV is a Class IIa medical device that uses Low-Intensity Vibration to gently stimulate bone mineral density, muscle strength and balance — without medication, physical strain or side effects.
The patient simply stands on the device for 10 minutes while the calibrated 30 Hz signal activates the skeletal system. The device auto-calibrates to body weight and shuts off when the session is complete.
At 0.4g, the signal sits well below occupational vibration thresholds and is designed for people with osteoporosis, osteopenia, cancer-related bone loss and other conditions where high-impact loading is unsuitable.
The technology was developed with NASA and the NIH to counter astronaut bone loss in microgravity. The platform represents nearly 40 years of research and more than USD $70 million in investment.
Designed for the people who need it most
Marodyne LiV is used daily by post-menopausal women, adults with osteopenia and osteoporosis, cancer survivors, elite athletes and clinicians looking for a non-drug, non-invasive way to support skeletal health, muscle strength and fall prevention.
Australian Register of Therapeutic Goods number 317506. Always read the label and follow directions for use.
The 10-minute daily ritual
The device automatically detects the user's body weight and calibrates the vibration frequency for the individual.
The 0.4g, 30 Hz mechanical signal travels from the feet through the hips, signalling osteoblasts to build new bone tissue.
After 10 minutes the device shuts off. The user has stimulated their body's natural bone remodelling and postural control mechanisms.
Born from spaceflight science
Discovered by Professor Clinton Rubin in collaboration with NASA to counter astronaut bone loss in microgravity, Low-Intensity Vibration delivers a precisely calibrated 0.4g signal at 30 Hz — safe enough for fragile bones, yet biologically potent enough to stimulate bone remodelling, muscle tone and balance.
The development represents nearly 40 years of research and over USD $70 million of investment, supervised by a scientific advisory board of leading experts in biomedicine, orthopaedics, osteoporosis, metabolism and rehabilitation medicine.
Proven by clinical data, not marketing
A curated selection of peer-reviewed research examining the safety and efficacy of Low-Intensity Vibration for bone density, falls prevention and musculoskeletal health.
Falls prevention
Leung et al., 2014; Cheung et al., 2016
Two long-term controlled trials in community-dwelling elderly women showed a 46% reduction in fall rate with Low-Intensity Vibration. Muscle strength and balance advantages were maintained a year after stopping treatment.
Bone microstructure
Randomised placebo-controlled trial (JBMR, 2020)
High-resolution MRI showed LiV improved trabecular bone microstructure and strength, and reduced marrow adiposity in pre-osteoporotic post-menopausal women — evidence at the tissue level, not just DEXA.
Postural stability after disuse
Muir, Judex, Qin, Rubin
A randomised trial showed that brief daily low-magnitude vibration protected postural control in adults exposed to prolonged bed rest — mirroring the disuse conditions that accelerate bone and balance loss with age.
Safety profile
JSMAS, 2013
Independent assessment of commercial vibration platforms found many exceed occupational safety thresholds. Marodyne's 0.4g signal at 30 Hz sits within safe, therapeutic limits for daily home use.
Technical specifications
| Therapeutic signal | 0.4g at 30 Hz |
|---|---|
| Amplitude | <0.1mm |
| Daily treatment time | 10 minutes |
| User position | Standing, weight-bearing |
| Auto-calibration | Yes — adjusts to user body weight |
| Weight | 8.1 kg |
| Dimensions | 7.7 cm H × 45.7 cm W × 35.6 cm D |
| Power | 100–240V AC 50–60Hz input; 16V DC, 70W max |
| Medical device classification | Class IIa |
| Australian regulatory listing | ARTG 317506 |
| Warranty | 2-year limited |
| In-box | Device, power supply, custom travel bag, instructions |
| Use environment | Home or clinical setting |
Why LiV is different
Low-Intensity Vibration occupies a unique position: it is a mechanical, non-drug therapy with strong clinical evidence, designed for patients who cannot tolerate high-impact loading or pharmacological side effects.
| Feature | Marodyne LiV | High-magnitude WBV | Drug therapy | Exercise alone |
|---|---|---|---|---|
| Mechanism | Low-Intensity Vibration (LiV) — 0.4g at 30 Hz | High-magnitude whole-body vibration (1–10g+) | Pharmacological bone remodelling agents | Progressive weight-bearing and resistance loading |
| Physical strain | None — passive standing | Moderate to high joint loading | Systemic, not mechanical | Can be limited by pain, frailty or injury |
| Suitable for fragile bones | Yes — designed for osteoporotic bone | Risk of microtrauma in high-risk patients | Varies by agent and contraindications | Requires careful dosing and supervision |
| Daily adherence | 10 minutes at home, easy to integrate | Typically gym or clinic based | Depends on medication schedule | Can be difficult to sustain long-term |
| Evidence base | NASA/NIH-funded, peer-reviewed RCTs | Mixed evidence, often fitness-focused | Well established but with side-effect profiles | Strong, but not always achievable |
The numbers, visualised
Three charts that explain why a signal this small produces a clinical effect this large, and why intensity is not the same thing as efficacy.
Signal intensity
0.4g at 30 Hz — below the safety guideline
1.0g daily-exposure reference
Typically 2–5g, unregulated
Up to 10g peak acceleration
Peak acceleration in g. The dashed line marks the 1.0g daily-exposure guideline referenced in the vibration safety literature; Marodyne LiV sits well below it, while typical fitness platforms sit far above.
Bone mineral density
% change in BMD over 12 months. Figures as reported in the Low-Intensity Vibration trial literature; individual results vary and depend on adherence, nutrition and concurrent care.
Falls prevention
Relative falls rate, indexed to the control group. Based on long-term controlled trials in community-dwelling elderly women (Leung et al., 2014; Cheung et al., 2016).
Not a vibration plate
The two look superficially similar. Clinically they are entirely different devices — different intensity, different regulatory class and different patient group.
| Specification | Marodyne LiV | Commercial vibration plate |
|---|---|---|
| Peak acceleration | 0.4g — precisely calibrated | 2–10g, varies with load and setting |
| Frequency | 30 Hz, fixed and verified | 5–50 Hz, user selectable |
| Amplitude | <0.1 mm | 1–10 mm |
| Regulatory status | Class IIa medical device, ARTG 317506 | Generally fitness equipment, unlisted |
| Session length | 10 minutes, auto shut-off | Open-ended, user set |
| Suitable for osteoporosis | Yes — designed for fragile bone | Frequently contraindicated |
| Auto-calibration to body weight | Yes | No |
| Weight | 8.1 kg — portable, travel bag included | 20–80 kg |
What to expect
Habit forms. Patients report improved standing tolerance and steadier gait; no measurable bone change yet.
Muscle strength and postural control improvements typically appear in balance testing well before DEXA change.
Bone remodelling becomes measurable. Trial data shows BMD gains of around 2% against continued loss in untreated controls.
Benefits are maintained with continued daily use; trial follow-up showed strength and balance advantages persisting a year after therapy stopped.
Applications
Addresses the steep bone-density decline that follows menopause through a non-drug, home-based daily intervention that fits around work and family.
Provides a clinically approved adjunct for patients who cannot tolerate, or do not want, pharmacological therapy alone.
Improves balance, muscle strength and postural control — the three modifiable factors most strongly linked to falls in the elderly.
Used to support skeletal health during and after treatment where bone density is compromised by therapy or hormonal changes.
Delivers a low-load anabolic signal that complements training and recovery where high-impact loading is being managed or reduced.
A take-home, clinician-recommended device that extends a practice's bone-health and falls-prevention service beyond the treatment room.
Falls prevention
Two long-term controlled trials in community-dwelling elderly women demonstrated significant reductions in fall rate — and lasting improvements in balance and muscle strength up to a year after therapy stopped. For a condition where one in three Australians over 65 falls each year, this is a clinically meaningful outcome.
Read the falls prevention researchQuestions
The vibration is very gentle — often described as a subtle buzz or hum. It is not a massage or a workout; the patient simply stands on the device for 10 minutes.
Bone remodelling is a slow process. Clinical trials typically measure outcomes over 12–18 months of consistent daily use, alongside standard care and nutrition.
Yes. Marodyne LiV is specifically designed for fragile bone. The 0.4g signal is well below the thresholds used by gym vibration plates and is ARTG-listed as a Class IIa medical device.
Yes. The device is designed for home use after initial guidance. It auto-calibrates and shuts off automatically after 10 minutes.
No prescription is required, but it is commonly recommended by clinicians, physiotherapists, chiropractors and general practitioners as part of a bone-health plan.
RehaCare is an authorised distributor for Marodyne LiV in Australia. Pricing, delivery and support are handled through our clinical team. Use the enquiry form or call 1300 653 522.
Australian enquiries
RehaCare is an authorised Marodyne LiV distributor in Australia and New Zealand. Tell us about your clinical caseload or patient profile and we will come back with pricing, support options and how the device fits into a bone-health or falls-prevention program.
Prefer to talk? Call 1300 653 522.
Visit Marodyne AustraliaBack to laser & clinic equipment